ReviewLeukemia supplements2012

Allogeneic stem cell transplant for myelofibrosis patients over age 60: likely impact of the JAK2 inhibitors.

V Fauble et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.